42 results
424B5
IFRX
InflaRx N.V.
28 Jun 24
Prospectus supplement for primary offering
4:56pm
to the currency introduced at the start of the third stage of European economic and monetary union pursuant to the treaty establishing the European Community … in their country of residence, such country of residence being another state of the European Union, Norway, Liechtenstein, Iceland or any other state with which
6-K
EX-99.1
IFRX
InflaRx N.V.
28 Jun 24
Leerink Partners LLC
4:55pm
Council, the European Union, His Majesty’s Treasury or other relevant sanctions authority (collectively, “Sanctions”), nor is the Company or any of its … with the European Union General Data Protection Regulations.
(bbb) Agent’s Activities. The Company acknowledges and agrees that the Agent has informed the Company
6-K
EX-99.2
IFRX
InflaRx N.V.
8 May 24
Report of Foreign Private Issuer
8:43am
of the European Union, or EU.
C5aR inhibitor INF904
Inhibition of the C5a/C5aR axis provides strong anti-inflammatory effects in a variety of diseases. Blockade
6-K
EX-99.3
IFRX
InflaRx N.V.
8 May 24
Report of Foreign Private Issuer
8:43am
for Human Use under the centralized procedure, which applies to all 27 member states of the European Union.
Vilobelimab abstract presentation at ATS 2024
6-K
EX-99.1
ythr2i zss
21 Mar 24
InflaRx Reports Full Year 2023 Results and Announces INF904 Development Plans
7:05am
6-K
EX-99.2
0jb1nwv j1
1 Nov 23
Current report (foreign)
8:04am
6-K
EX-99.3
yt7k f86j
1 Nov 23
Current report (foreign)
8:04am
6-K
EX-99.1
og3jq85hfuk1
30 Aug 23
Current report (foreign)
8:00am
F-3
EX-4.3
4e33p acdta6nr
30 Jun 23
Shelf registration (foreign)
4:06pm
F-3
EX-5.1
99z 1jcpp6maz0zlawf
30 Jun 23
Shelf registration (foreign)
4:06pm
F-3
EX-4.2
f2jlbmf6dq6bvvv01v1u
30 Jun 23
Shelf registration (foreign)
4:06pm
6-K
EX-5.1
yapam58rk5
13 Apr 23
Current report (foreign)
4:01pm
6-K
EX-1.1
43xdizv1
13 Apr 23
Current report (foreign)
4:01pm
424B5
ely7q4pfwm32 qpeb
13 Apr 23
Prospectus supplement for primary offering
8:48am
424B5
agd8e 4xsur
11 Apr 23
Prospectus supplement for primary offering
4:11pm
6-K
EX-99.3
dvlta
9 Nov 22
Current report (foreign)
7:52am